Literature DB >> 7361862

Partial characterization of a bone-derived chemotactic factor for tumor cells.

F W Orr, J Varani, M D Gondek, P A Ward, G R Mundy.   

Abstract

Medium that has been bathing organ cultures of resorbing bone contains a factor that is chemotactic for cultured Walker carcinosarcoma cells, as assayed by the Boyden chamber technique. There is a positive correlation between the chemotactic activity released by the resorbing bones and the extent of resorption as measured by release of previously incorporated 45Ca from the bones. Generation of the chemotactic factor occurs independent of the humoral mediator of bone resorption. The tumor cell chemotactic factor has a steep dose-response curve, with a fall from maximal to minimal activity extending over a four-fold dilution. The chemotactic activity is stable to heating and has an estimated molecular weight of 6000 daltons, as determined by gel filtration chromatography and retention of activity following dialysis. The chemotactic activity has been distinguished from the tumor cell chemotactic factor derived from the fifth component of complement because the former is not inactivated by antiserum to C5 and because it is chemotactic for EL-4 lymphoma cells, whereas the latter is not chemotactically active for these cells.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7361862      PMCID: PMC1903471     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  19 in total

1.  Release of osteoclast activating factor by normal human peripheral blood leukocytes.

Authors:  C L Trummel; G R Mundy; L G Raisz
Journal:  J Lab Clin Med       Date:  1975-06

2.  A unique complement derived chemotactic factor for tumor cells.

Authors:  A G Romualdez; P A Ward
Journal:  Proc Natl Acad Sci U S A       Date:  1975-10       Impact factor: 11.205

3.  Studies on the mechanisms of invasion in cancer. II. In vivo effects of a factor chemotactic for cancer cells.

Authors:  T Ozaki; K Yoshida; K Ushijima; H Hayashi
Journal:  Int J Cancer       Date:  1971-01-15       Impact factor: 7.396

4.  Studies on the mechanisms of invasion in cancer. I. Isolation and purification of a factor chemotactic for cancer cells.

Authors:  K Yoshida; T Ozaki; K Ushijima; H Hayashi
Journal:  Int J Cancer       Date:  1970-07-15       Impact factor: 7.396

5.  Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis.

Authors:  U R Nilsson; R H Tomar; F B Taylor
Journal:  Immunochemistry       Date:  1972-07

6.  Relationship between the C5 peptides chemotactic for leukocytes and tumor cells.

Authors:  A G Romualdez; P A Ward; T Torikata
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

7.  The hypercalcaemic syndrome in rats bearing the Walker carcinosarcoma 256.

Authors:  H Minne; F Raue; S Bellwinkel; R Ziegler
Journal:  Acta Endocrinol (Copenh)       Date:  1975-03

8.  Mechanisms and prevention of cancer dissemination: an overview.

Authors:  E V Sugarbaker; A S Ketcham
Journal:  Semin Oncol       Date:  1977-03       Impact factor: 4.929

9.  Complement-derived leukotactic factors in inflammatory synovial fluids of humans.

Authors:  P A Ward; N J Zvaifler
Journal:  J Clin Invest       Date:  1971-03       Impact factor: 14.808

10.  The inhibition by aspirin and indomethacin of osteolytic tumor deposits and hypercalcaemia in rats with Walker tumour, and its possible application to human breast cancer.

Authors:  T J Powles; S A Clark; D M Easty; G C Easty; A M Neville
Journal:  Br J Cancer       Date:  1973-10       Impact factor: 7.640

View more
  12 in total

Review 1.  [Importance of fibroblast chemotaxis in wound healing and tumor cell evasion].

Authors:  H Mensing
Journal:  Klin Wochenschr       Date:  1985-02-15

2.  Induction of monocyte chemotaxis in devascularized rabbit bone.

Authors:  M R Sarkar; B A Rahn; U Pfister; H U Keller; S M Perren
Journal:  Arch Orthop Trauma Surg       Date:  1990       Impact factor: 3.067

3.  Unidirectional migration of osteosarcoma cells with osteoblast characteristics in response to products of bone resorption.

Authors:  G R Mundy; S B Rodan; R J Majeska; S DeMartino; C Trimmier; T J Martin; G A Rodan
Journal:  Calcif Tissue Int       Date:  1982       Impact factor: 4.333

4.  Collagen and collagen-derived fragments are chemotactic for tumor cells.

Authors:  G R Mundy; S DeMartino; D W Rowe
Journal:  J Clin Invest       Date:  1981-10       Impact factor: 14.808

5.  LCC15-MB: a vimentin-positive human breast cancer cell line from a femoral bone metastasis.

Authors:  E W Thompson; V Sung; M Lavigne; K Baumann; N Azumi; A D Aaron; R Clarke
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

6.  Platelet factors induce chemotactic migration of murine mammary adenocarcinoma cells with different metastatic capabilities.

Authors:  M A Sarach; R A Rovasio; A R Eynard
Journal:  Int J Exp Pathol       Date:  1993-10       Impact factor: 1.925

Review 7.  Mechanisms involved in the metastasis of cancer to bone.

Authors:  F W Orr; P Kostenuik; O H Sanchez-Sweatman; G Singh
Journal:  Breast Cancer Res Treat       Date:  1993       Impact factor: 4.872

8.  Chemotactic activity of the gamma-carboxyglutamic acid containing protein in bone.

Authors:  G R Mundy; J W Poser
Journal:  Calcif Tissue Int       Date:  1983       Impact factor: 4.333

9.  A quantitative model for spontaneous bone metastasis: evidence for a mitogenic effect of bone on Walker 256 cancer cells.

Authors:  P J Kostenuik; G Singh; K L Suyama; F W Orr
Journal:  Clin Exp Metastasis       Date:  1992-11       Impact factor: 5.150

10.  H-31 human breast cancer cells stimulate type I collagenase production in osteoblast-like cells and induce bone resorption.

Authors:  K Ohishi; N Fujita; Y Morinaga; T Tsuruo
Journal:  Clin Exp Metastasis       Date:  1995-07       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.